Trials / NCT01497379
Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Completed N/A Gene therapy, Retinal implant
- Sponsor
- Retina Implant AG
- Treatment
- surgical implantation of subretinal device; surgical implantation of subretinal device
- Gene
- Not stated
- Conditions
- Retinal Degeneration, Retinitis Pigmentosa
- Ages
- 18 Years to 78 Years
- Enrollment
- 2 participants
- Started
- 2011-10
- Main results expected
- 2014-01
- Results posted
- Not yet
- Record last updated
- 2017-03-29
What the study is testing
Patients who are legally blind, caused by retinal degeneration of photoreceptor rods \& cones (e.g. Retinitis pigmentosa), receive a subretinal implant to restore vision partially.
Where it runs
Hong Kong (1)
- Ophthalmology Eye Institute, University of Hong Kong, Hong Kong, Cyberport